NOVO NORDISK INC. for NOVO NORDISK INC.
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Issues related to insulin pen safety and access in the VA
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Copyright/Patent/Trademark CPT
H.R. 3309 Innovation Act and S. 1720 Patent Transparency and Improvements Act of 2013 (patent litigation and assertion); demand letters
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Health Issues HCR
National Diabetes Prevention Program; Better care and treatment of people with diabetes under P.L. 111-148 Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152 The Health Care & Education Affordability Reconciliation Act of 2010: Issues related to diabetes generally, and specifically diabetes screening, medical education and death certificate reporting (Catalyst for Better Diabetes), AHRQ and USPSTF diabetes screening standards;diabetes issues in Healthy People 2020 and the Office of Disease Prevention and Health Promotion (ODPHP); H.R. 1074 and S. 539 National Diabetes Clinical Care Commission Act of 2013; S.RES.242 and H.RES.313 Supporting the goals and ideals of "Growth Awareness Week" and the MAGIC Foundation; H.R. 4302, Protecting Access to Medicare Act; S. 2157, Commonsense Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 (Special Diabetes Program reauthorization); H.R. 1915 and S. 907 Gestational Diabetes Act of 2013; H.R. 3322, Eliminating Disparities in Diabetes Prevention, Access, and Care Act of 2013; H.R. 351 and S. 351 Protecting Seniors' Access to Medicare Act of 2013 (IPAB repeal)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Medicare/Medicaid MMM
H.R. 962 and S. 452 Medicare Diabetes Prevention Act of 2013; Issues related to Medicare Part D and Medicaid rebates as contained in P.L. 112-25 Budget Control Act of 2011 and H.R. 8 American Taxpayer Relief Actof 2012; H.R. 1588 & S. 740 Medicare Drug Savings Act of 2013; H.R. 1257 Preventing Diabetes in Medicare Act of 2013 and prediabetes generally; H.R. 1274 and S 945 Access to Quality Diabetes Education Act of 2013 (Diabetes Self-Management Training in Medicare);Medicare diabetes screening generally; S. 1184 and H.R. 2415 Treat and Reduce Obesity Act of 2013; Diabesity amendment to S. 1871 SGR Repeal and Medicare Beneficiary Access; Physician Quality and Reporting System (PQRS)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Budget/Appropriations BUD
Issues related to Medicare Part D, FDA and patents in S. Con. Res. 8; FY14 Omnibus; H. Con Res. 25 House Budget Resolution; H.R. 2663 and S. 1422 The Preventative Health Savings Act of 2013 (Modernizing CBO scoring with respect to preventive health legislation); National Diabetes Prevention Program; HR 933 -- Consolidated and Further Continuing Appropriations Act, 2013; FY15 Labor/HHS/Education Appropriations (National Diabetes Prevention Program);H.J. Res. 59 FY14 Continuing Appropriations Resolution (contains Bipartisan Budget Act of 2013). H Con Res 96 the House FY 2015 Budget
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Pharmacy PHA
HR 3204, S. 959 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Trade (domestic/foreign) TRD
EU/US Transatlantic Trade and Investment Partnership (TTIP) (intellectual property)
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Taxation/Internal Revenue Code TAX
R&D Tax Credit;H.R. 2052 and S. 1023 Global Investment in American Jobs Act of 2013
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN BRANTON | — |
| TRICIA BROOKS | — |
| CHRISTOPHER MCGOWEN | — |
| SARAH ELIZABETH NORDSTROM | — |
| CHRISTOPHER PORTER | — |
| LAUREN ELIZABETH SEMENIUK | — |
| AMY CATHERINE THIENEL | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| NOVO NORDISK FONDEN (FOUNDATION) | Denmark | Denmark | 25.5% | — |
| NOVO NORDISK A/S | Denmark | Denmark | 100.0% | — |
| NOVO A/S | Denmark | Denmark | 25.5% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.